UC Davis Children’s Hospital

Karen Jo Doyle, M.D., Ph.D. View profile as PDF

Karen Jo Doyle

Clinical/Research Interests

Dr. Doyle's otology/neurotology practice concentrates on surgical treatment of ear and balance disorders including hearing loss, ear infections, balance disturbances, vertigo syndromes, and other conditions that produce hearing and balance problems.

Research Focus

Dr. Doyle has two research areas: Identification of hearing loss in infants The effects of ototoxic medications on the inner ear

Title:

Professor

Specialty:

Otolaryngology

Address:

Glassrock Building
2521 Stockton Blvd., Suite 7200
Sacramento, CA 95817

Phone:

(916) 734-2801

Education:

UC San Francisco School of Medicine
San Francisco, California
M.D. 1986

UC Santa Barbara
Santa Barbara,
Ph.D. 1984

University of Michigan
Ann Arbor, Michigan
B.A. 1976

Internships:

University of California
San Francisco, CA
1988

Residency:

University of California, San Francisco Hospitals
San Francisco, California
1992
Surgery

Fellowships:

House Ear Clinic
Los Angeles , California
1993
Otology/Neurotology

Board Certifications:

American Board of Otolaryngology, 1993

Professional Memberships:

Alumni Fellowship Group of the House Ear Institute
American Academy of Otolaryngology-Head and Neck Surgery
American Auditory Society
American Neurotology Society
American Otological Society
Association for Research in Otolaryngology
Sacramento Society of Otolaryngology
Society of University Otolaryngologists
Triological Society

Honors and Awards:

Chair, Hearing Committee, American Neurotology Society, Null
Elected Board Member, American Auditory Society, 2002
Coordinator, Otology/Neurotology Section, National Resident Curriculum Committee, American Academy of Otolaryngology-Head and Neck Surgery Foundation, 2001
Best Doctors in America, Otolaryngology, 1998-2001
Phi Bet Kappa, 1976

Select Recent Publications:

Nie L, Feng W, Diaz R, Gratton MA, Doyule KJ, Yamoah EN. Functional consequenses of inhibition of polyamine synthesis by DFMO: Cellular mechanisms for DFMO-mediated ototoxicity. Journal of Biological Chemistry 2005

Doyle KJ, et all. Intratympanic steroid treatment: A review. Otology and Neurotology 2004;25:1034-9.

Smith M, Doyle KJ, Tinling SP. DFMO-induced hearing loss across wide frequency range. Laryngoscope 2004:114:1113-17.

Rosenfeld RM, Culpepper L, Doyle KJ, Grundfast KM, Hoberman A, Kenna MA, Lieberthal AS, Mahoney M, Wahl RA, Woods CR, Yawn B. Clinical Practice guideline: Otitis media with effusion. Otolaryngolgy Head Neck Surg 2004: 130(5Suppl):S95-S118.

Doyle KJ, Kong YY, Strobel K, Dallaire P, Ray RM. Neonatal middle ear effusion predicts chronic otitis media with effusion. Otology & Neurotology 2004: 25:318-22.

Grandis J, Zanboni G, Wagener M, Miller , Doyle KJ, NcJubbib S. The gender gap in surgical subspecialty: analysis of career and lifestyle factors. Arch Otolaryngol Head Neck Surg 2004; 130:695-702

Buckmiller LM, Brodie HA, Doyle KJ, Nemzek W. Choristoma of the middle ear: A component of a new syndrome? Otology & Neurotology 2001;22:363-8.

Doyle KJ. Delayed, reversible hearing loss caused by difluoromethylornithine (DFMO). Laryngoscope 2001;111:781-5.

Doyle KJ, Meyskens FL, McLaren C, Shanks J, Galus C. Effects of DFMO chemoprevention on audiometry thresholds and otoacoustic emissions. Arch Otolaryngol Head Neck Surg 2001; 127:553-8.

To see if Karen Jo Doyle is accepting new patients, or for assistance finding a UC Davis doctor, please call (800) 2-UC DAVIS.